Skip to main content

Pomalyst is still working!

Edie has started on her second round of Pomalyst, and the results just keep getting better.

Her Kappa freelight chains are now down to 36 from the 175 about 3 weeks ago. The normal [reference] range is 5 to 19, so there is still a little ways to go, but at least there is progress. Her numbers haven't been this low since after her transplant in October 2008. (It's hard to believe it's been almost 5 years now.)

The only question remaining, as it was was when she first started on the drug, is how long to take it? There doesn't appear to be a good answer for that. Since this drug is so new, there's not a lot of information about how long to stay on it, or even how long is safe to stay on it. Fortunately there doesn't appear to be any significant side effect which can be attributed to the Pomalyst, and which could prevent its further use.

So for now the plan is to finish this cycle, and then see what her numbers are at the end and how she's doing, and then decide.

I'm just thankful I'm not in this position. I doubt I would be as stoic as Edie has been through this entire ordeal.

 

 

 
Labels:

Comments

Post a Comment

Popular posts from this blog

My concerns reaffirmed today

When I was first diagnosed with MCL, I pretty much read just about everything I could get my hands on, I attended various conferences, and I talked to anyone who would listen. One of the most important lessons I learned, and which I've mentioned numerous times before was No one cares more about you than you. But in addition to that, I learned to fear the drug Doxorubicin , AKA Adriamycin, Doxil, Hydroxydoxorubicin, or more affectionately the Red Devil. Besides being a deadly chemical, as is the case with most chemotherapy drugs, it is one of the few chemotherapy drugs known to cause permanent heart damage. I even heard Dr. Sandra Horning , a noted Stanford lymphoma specialist, state at the first lymphoma conference I attended in LA, there was no evidence Doxorubicin provided any added benefit to chemotherapy protocols. This was music to my ears, since Doxorubicin is very common in most lymphoma treatment protocols. And even though Dr. Horning has since changed her tune [which my sk...
Post a Comment
Read more

Bowling: A metaphor on life [sorta]

Over the past 15+ years the game of bowling has changed dramatically. Not only has the equipment changed, making it easier for bowlers of all ages and physical conditions to participate, and score well, but there have even been major advances to how the lanes are prepared for the start of bowling. No longer is it just heavy oil, light oil, long oil, short oil, or no oil, with the latest equipment, the amount of oil can be varied from front to back and side to side, producing a myriad of patterns designed to make the game more interesting, more challenging and as you might surmise, more frustrating. No longer does the "one ball fits all" approach work any more either. In order to navigate all the differing possible lane conditions, you need to have a varied selection of bowling balls. Most pros will tell you the average bowler needs 3 balls, plus a ball for spares, but to be an above average bowler you'll need at least 6 balls, with many possessing more than that. But just...
1 comment
Read more

Fatigue! Part II - Maybe it is real?

Or it's actually Motivational Deficiency Disorder, MoDeD (pronounced Mo-Dee-Dee) for short. In a report this week by Roy Moynihan who reports for the British Medical Journal Austrailian scientists may have come across the reason for extreme laziness . The condition is claimed to affect up to one in five Australians and is characterised by overwhelming and debilitating apathy. Neuroscientists at the University of Newcastle in Australia say that in severe cases motivational deficiency disorder can be fatal, because the condition reduces the motivation to breathe. Neurologist Leth Argos is part of the team that has identified the disorder, which can be diagnosed using a combination of positron emission tomography and low scores on a motivation rating scale, previously validated in elite athletes. "This disorder is poorly understood," Professor Argos told the BMJ. "It is underdiagnosed and undertreated." Who knew? Maybe I have MoDeD, from my attempts to become a...
Post a Comment
Read more